SS
XERS icon

SBI Securities’s Xeris Biopharma Holdings XERS Stock Holding History

SBI Securities’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Hold
1,907
– – ﹤0.01% 1648
2026
Q1 		$11.1K Hold
1,907
– – ﹤0.01% 1681
2025
Q4 		$15K Sell
1,907
-6
-0.3% -$47 ﹤0.01% 1561
2025
Q3 		$15.6K Buy
1,913
+6
+0.3% +$40 ﹤0.01% 1558
2025
Q2 		$8.91K Hold
1,907
– – ﹤0.01% 1752
2025
Q1 		$10.5K Sell
1,907
-10
-0.5% -$40 ﹤0.01% 1589
2024
Q4 		$6.5K Buy
+1,917
New +$6.17K ﹤0.01% 1821

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SBI Securities's XERS Position: Q2 2026 in Review

SBI Securities held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 1,907 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1648.

SBI Securities first reported a position in XERS in Q4 2024 and has held it in 7 quarters since. The position peaked at $15.6K in Q3 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • SBI Securities held 1,907 shares of Xeris Biopharma Holdings worth $15.1K as of Q2 2026.
  • SBI Securities left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1648 holding.
  • SBI Securities first reported a position in Xeris Biopharma Holdings in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Xeris Biopharma Holdings position peaked at $15.6K in Q3 2025.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.